Horizon Pharma plc 4
4 · Horizon Pharma plc · Filed Oct 2, 2014
Insider Transaction Report
Form 4
DE VAERE ROBERT J
EVP and CFO
Transactions
- Award
Ordinary Shares
2014-09-30+112,166→ 206,456 total - Sale
Ordinary Shares
2014-09-30$12.28/sh−51,942$637,848→ 154,514 total
Footnotes (3)
- [F1]Fully vested restricted stock units issued on the Separation Date as defined in that certain Executive Employment and Transition Agreement dated June 17, 2014.
- [F2]Includes 23,467 shares of the Company's ordinary shares acquired pursuant to an employee stock purchase program.
- [F3]Reflects restricted stock units surrendered via a net settlement to satisfy tax withholding obligations in connection with the vesting of a restricted stock unit.